TRE-KRAB-dCas9-IRES-GFP Citations (7)
Originally described in: Systematic mapping of functional enhancer-promoter connections with CRISPR interference.Fulco CP, Munschauer M, Anyoha R, Munson G, Grossman SR, Perez EM, Kane M, Cleary B, Lander ES, Engreitz JM Science. 2016 Sep 29. pii: aag2445. PubMed Journal
Articles Citing TRE-KRAB-dCas9-IRES-GFP
| Articles |
|---|
| De Novo PITX1 Expression Controls Bi-Stable Transcriptional Circuits to Govern Self-Renewal and Differentiation in Squamous Cell Carcinoma. Sastre-Perona A, Hoang-Phou S, Leitner MC, Okuniewska M, Meehan S, Schober M. Cell Stem Cell. 2019 Mar 7;24(3):390-404.e8. doi: 10.1016/j.stem.2019.01.003. Epub 2019 Jan 31. PubMed |
A doxycycline- and light-inducible Cre recombinase mouse model for optogenetic genome editing.
Vizoso M, E J Pritchard C, Bombardelli L, van den Broek B, Krimpenfort P, Beijersbergen RL, Jalink K, van Rheenen J.
Nat Commun. 2022 Oct 28;13(1):6442. doi: 10.1038/s41467-022-33863-z.
PubMed
Associated Plasmids |
| Epigenomic mapping reveals distinct B cell acute lymphoblastic leukemia chromatin architectures and regulators. Barnett KR, Mobley RJ, Diedrich JD, Bergeron BP, Bhattarai KR, Monovich AC, Narina S, Yang W, Crews KR, Manring CS, Jabbour E, Paietta E, Litzow MR, Kornblau SM, Stock W, Inaba H, Jeha S, Pui CH, Mullighan CG, Relling MV, Pruett-Miller SM, Ryan RJH, Yang JJ, Evans WE, Savic D. Cell Genom. 2023 Nov 20;3(12):100442. doi: 10.1016/j.xgen.2023.100442. eCollection 2023 Dec 13. PubMed |
| Genome-wide quantification of copy-number aberration impact on gene expression in ovarian high-grade serous carcinoma. Jamalzadeh S, Dai J, Lavikka K, Li Y, Jiang J, Huhtinen K, Virtanen A, Oikkonen J, Hietanen S, Hynninen J, Vaharautio A, Hakkinen A, Hautaniemi S. BMC Cancer. 2024 Feb 5;24(1):173. doi: 10.1186/s12885-024-11895-6. PubMed |
| Selective Enhancer Dependencies in MYC-Intact and MYC-Rearranged Germinal Center B-cell Diffuse Large B-cell Lymphoma. Iyer AR, Gurumurthy A, Chu SA, Kodgule R, Aguilar AR, Saari T, Ramzan A, Rosa J, Gupta J, Emmanuel A, Hall CN, Runge JS, Owczarczyk AB, Cho JW, Weiss MB, Anyoha R, Sikkink K, Gemus S, Fulco CP, Perry AM, Schmitt AD, Engreitz JM, Brown NA, Cieslik MP, Ryan RJH. Blood Cancer Discov. 2025 May 5;6(3):233-253. doi: 10.1158/2643-3230.BCD-24-0126. PubMed |
| Three-dimensional regulatory hubs support oncogenic programs in glioblastoma. Breves SL, Di Giammartino DC, Nicholson J, Cirigliano S, Mahmood SR, Lee UJ, Martinez-Fundichely A, Jungverdorben J, Singhania R, Rajkumar S, Kirou R, Studer L, Khurana E, Polyzos A, Fine HA, Apostolou E. Mol Cell. 2025 Apr 3;85(7):1330-1348.e6. doi: 10.1016/j.molcel.2025.03.007. Epub 2025 Mar 26. PubMed |
| The regulatory landscape of nascent transcription in human health and disease. Shah SR, Chen Y, Leung AK, Navarro PVC, Paramo MI, Gupta J, Gurumurthy A, Fite RF, Weimer AK, Du Q, Mohyeldin AM, Egli D, Creusot RJ, Ryan RJH, Snyder MP, Clark AG, Lis JT, Yu H. bioRxiv [Preprint]. 2025 Sep 26:2025.09.24.676871. doi: 10.1101/2025.09.24.676871. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.